Impact of antitumor regimens on the outcomes of cancer patients with COVID-19:a pooled analysis

• 作者: Haohua LU Yu SHI Kelie CHEN Zhi CHEN Haihong ZHU Yuequn NIU Dajing XIA Yihua WU
• 来源期刊: 浙江大学学报（英文版）（B辑：生物医学和生物技术）
• 年，卷（期）: 2021,（10）
• 所属期刊栏目: Correspondence
• 页码范围: 876-884,后插1-后插5
• 页数: 1页
• 语种: 英文

摘要

Since the outbreak of coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) discovered in December 2019, the disease has emerged as a global pandemic (Shi et al., 2020;World Health Organization, 2020). Several studies have shown a higher incidence of COVID-19, as well as related poor outcomes in patients with malignancies as compared with those without them (Liang et al., 2020;Tian et al., 2020).